Omicia to Put Annotation Tools To Work Analyzing Sequence Data for Genomic Cancer Care Alliance

An Omicia spokesperson told BioInform that the company will work closely with the sequencing companies in the alliance to process, annotate, and interpret raw cancer genome data and convert it into a useful format for clinicians.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.